Other Clinical Trial - A Dose-Escalation Study of MDX-010 Administered

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT02511496` - Status of Chronic Liver Disease in Hepatitis C Virus (HCV) Patients Coinfected With Human Immunodeficiency Virus (HIV) in Andalusia	N/A
Completed	`NCT02234492` - The Effects of Statin Therapy on Coronary Flow Reserve and Inflammatory Markers in HIV-Positive Patients	Phase 4
Completed	`NCT02027441` - Enhanced Prevention in Couples: Feasibility Study #2	N/A
Completed	`NCT01685372` - Immunogenicity of Fluzone High Dose in Immunocompromised Children and Young Adults	Phase 2
Completed	`NCT02165202` - Phase II Safety and Acceptability of an Investigational Injectable Product, TMC278LA, for Pre-Exposure Prophylaxis	Phase 2
Completed	`NCT01615601` - An Observational Study to Evaluate Tolerability of PREZISTA or INTELENCE in HIV-1 Infected Patients	Phase 4
Terminated	`NCT01448486` - A Study of the Neurological Effects of Adding Raltegravir to HAART Regimen in Patients With HIV	Phase 4
Completed	`NCT02572401` - Steering Together in a New Direction: Reducing the Risk of HIV/STD Among African American Men	N/A
Completed	`NCT01449006` - A Study of the Neurological Effects of Adding Maraviroc to HAART Regimen in Patients With HIV (HANDmac)	Phase 4
Completed	`NCT04122404` - POC Strategies to Improve TB Care in Advanced HIV Disease	N/A
Completed	`NCT03290755` - Sexual Hepatitis C in HIV Positive Men Who Have Sex With Men (MSM) in Bordeaux
Completed	`NCT02974998` - Cape Town Young Women's Health CoOp	N/A
Completed	`NCT01516970` - Human Immunodeficiency Virus (HIV) Postexposure Prophylaxis (PEP) With Darunavir/Ritonavir (DRV/r)	Phase 3
Completed	`NCT01997346` - Multi-level Determinants of Starting ART Late: Aim 2	N/A
Active, not recruiting	`NCT01875952` - Diagnosis and Treatment of Co-infection With Human Immunodeficiency Virus /Latent Tuberculosis Infection (HIV/TBL)	Phase 4
Completed	`NCT01199939` - A Study of the Once Daily Combination of Etravirine and Darunavir/Ritonavir As Dual Therapy in Early Treatment-Experienced Patients	Phase 2
Completed	`NCT03783130` - Dose, Safety, Tolerability, and Immunogenicity of an HIV-1 Vaccine, VRC-HIVRGP096-00-VP, With Alum in Healthy Adults	Phase 1
Recruiting	`NCT05657106` - Kentucky Outreach Service Kiosk (KyOSK): Reducing HIV, HCV, and Overdose Risk	N/A
Not yet recruiting	`NCT05727033` - Extraordinarily Fun Training Project in Compulsory Secondary Education - Sexually Transmitted Infections	N/A
Completed	`NCT01053741` - Effect of Seminal Fluid on the Colon Wall; Implications for HIV Transmission	N/A

NCT number	NCT03407105
Study type	Interventional
Source	Bristol-Myers Squibb
Contact
Status	Completed
Phase	Phase 1
Start date	April 21, 2003
Completion date	February 21, 2006

A Dose-Escalation Study of MDX-010 Administered Monthly as Immunotherapy in Subjects Infected With Human Immunodeficiency Virus (HIV)

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms